Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study.
about
Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.Vitamin D deficiency--prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis--a prospective multicenter studyParathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging StudyParathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studiesParathyroid Hormone Levels in the Prediction of Ischemic Stroke RiskAssociation of parathyroid hormone with 20-year cognitive decline: The ARIC study.Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.Independent and Synergistic Associations of Biomarkers of Vitamin D Status With Risk of Coronary Heart Disease.Physical Activity and Lifetime Risk of Cardiovascular Disease and Cancer.High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort studyKidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.25-Hydroxyvitamin D insufficiency discriminates cardiovascular risk factors accumulation in peri-pubertal boys undergoing overweight screening.Parathyroid Hormone (PTH) Assays and Applications to Bone Disease: Overview on MethodologyParathyroid Hormone (PTH) Assays and Applications to Bone Disease: Overview on Methodology
P2860
Q35115028-F85DD0B0-752E-4A08-9A31-8574435CA69DQ35597780-0E6D1C96-EE5E-4D38-8DDD-B9B1FE1BB8AEQ36706182-211A5310-02C8-4B6E-B822-87AD821AE309Q37328775-291A4945-3359-4FE8-AC77-407334150434Q37587420-F3FE3762-3012-4955-8A17-7AB4EF8DBAFFQ38646001-0FA5BE5C-56C8-449D-814B-3315ABACCD4CQ38730259-9556E7F8-6194-4F30-9A05-DDC29E0D2574Q40052504-1FDD6EC3-877D-4C9F-98D4-227D5EF03E1CQ40270280-D0DF337A-45FE-460E-A61E-D99BAC3F9BFAQ40370710-90E196F5-93C3-429E-9A27-31BA8D4C900FQ40627550-930E3715-5138-48EC-A99E-D6870942367DQ41531107-B6767023-A4BE-4831-882E-7BEC435873AEQ46009914-53499719-10F3-444E-B375-2E346B5E33E7Q51297765-1FF41430-1FF8-4C50-A871-F8AE9C1DA0C3Q58634097-738ABBDE-850A-4FEC-A147-7F1D86670DD5Q58634182-8028121C-0AAF-4505-B607-46FA66763739
P2860
Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Parathyroid hormone concentrat ...... k in Communities (ARIC) study.
@ast
Parathyroid hormone concentrat ...... k in Communities (ARIC) study.
@en
Parathyroid hormone concentrat ...... osclerosis Risk in Communities
@nl
type
label
Parathyroid hormone concentrat ...... k in Communities (ARIC) study.
@ast
Parathyroid hormone concentrat ...... k in Communities (ARIC) study.
@en
Parathyroid hormone concentrat ...... osclerosis Risk in Communities
@nl
prefLabel
Parathyroid hormone concentrat ...... k in Communities (ARIC) study.
@ast
Parathyroid hormone concentrat ...... k in Communities (ARIC) study.
@en
Parathyroid hormone concentrat ...... osclerosis Risk in Communities
@nl
P2093
P2860
P50
P1476
Parathyroid hormone concentrat ...... k in Communities (ARIC) study.
@en
P2093
Aaron R Folsom
John H Eckfeldt
Pamela L Lutsey
P2860
P304
P356
10.1016/J.AHJ.2014.04.017
P407
P577
2014-06-09T00:00:00Z